IL17A and multidrug-resistant tuberculosis: In our previous study we detected that MDR-TB patients more remarkably suppressed Th1 and Th2 cell response and more significantly enhanced IL-17 expression versus DS-TB according to our publications13,15, which are characterized in early infection of MDR-TB.